Balaxi Pharmaceuticals Limited

NSE BALAXI.NS

Balaxi Pharmaceuticals Limited Interest Coverage Ratio for the year ending March 31, 2024: 25.97

Balaxi Pharmaceuticals Limited Interest Coverage Ratio is 25.97 for the year ending March 31, 2024, a 105.87% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Balaxi Pharmaceuticals Limited Interest Coverage Ratio for the year ending March 31, 2023 was -442.53, a 63.92% change year over year.
Balaxi Pharmaceuticals Limited Interest Coverage Ratio for the year ending March 31, 2022 was -1,226.52, a 84.35% change year over year.
Balaxi Pharmaceuticals Limited Interest Coverage Ratio for the year ending March 31, 2021 was -7,836.40, a -1,185.25% change year over year.
Balaxi Pharmaceuticals Limited Interest Coverage Ratio for the year ending March 31, 2020 was -609.72.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

NSE: BALAXI.NS

Balaxi Pharmaceuticals Limited

CEO	Ashish Maheshwari
IPO Date	Dec. 2, 2015
Location	India
Headquarters	MAPS Towers
Employees	51
Sector	Consumers Staples
Industries Retail & Wholesale Cleaning Supplies Consumer Packaged Goods Drugstores & Retail Pharmacies Glass Hardware & Electronics Non-Alcoholic Beverages Pharmaceuticals

Description

Balaxi Ventures Ltd. engages in the wholesale trading of pharmaceuticals, food products, and hardware. The company is headquartered in Hyderabad, Telangana. The Company’s products include pharmaceuticals products, food products and builders’ hardware products. The company operates through the operating segment international wholesale trading. Its pharmaceutical formulations and builders’ hardware products are contract manufactured from manufacturing plants in India. The firm offers a range of food and biscuit products under the brand name YAP. Its subsidiaries include Balaxi Global DMCC.

Key trends

Past 5 years